COLORECTAL CARCINOMA
Clinical trials for COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for advanced colorectal cancer shows promise in early trial
Disease control TerminatedThis study tested a combination of two drugs, VB-111 and nivolumab, in 14 adults with metastatic colorectal cancer that had spread to the liver. The goal was to see if the treatment could shrink tumors and be safe. The trial was stopped early, but the results help researchers und…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New cancer drug trial halted early after testing in just 10 patients
Disease control TerminatedThis early-phase study tested a new drug (PF-07826390) alone or with another drug (sasanlimab) in 10 people with advanced solid tumors like lung, colon, or kidney cancer. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Polyp-Fighting drug falls short in rare cancer syndrome trial
Disease control TerminatedThis study tested a daily pill called obeticholic acid (OCA) in 15 people with familial adenomatous polyposis (FAP), a genetic condition that causes hundreds of polyps in the intestines and raises cancer risk. The goal was to see if OCA could safely shrink the number of polyps in…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Pfizer's new cancer drug shows early promise in small trial
Disease control TerminatedThis early-stage study tested a new drug, PF-07820435, alone or with another drug (sasanlimab), in 9 people with advanced solid tumors like lung, skin, and kidney cancers. The main goal was to check safety and find the right dose. The study was stopped early, so results are limit…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:53 UTC